FdaApplication
NDA 208611
Identifiers
- fda_app_no: NDA208611
Properties
| Property | Value |
|---|---|
| applicant_name | MELINTA SUBSIDIARY CORP |
| application_type | NDA |
| approval_date | 2017-06-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BAXDELA | DELAFLOXACIN MEGLUMINE | EQ 300MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product